Neurons of AD transgenic mice were shown to display enlarged MVBs as compared to the neurons of wild-type mice, and ESCRT was demonstrated to modulate intracellular Aβ42 accumulation by directing APP to lysosomal degradation and by enhancing Aβ42 secretion. The gene discussed is APP; the disease is Alzheimer disease.